A case of Merkel cell carcinoma development under treatment with a Janus kinase inhibitor.

Koike, Yuta; Murayama, Naoya; Kuwatsuka, Yutaka; Utani, Atsushi.

Afiliação

Koike Y; Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Murayama N; Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Kuwatsuka Y; Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Utani A; Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

JAAD Case Rep ; 3(6): 498-500, 2017 Nov.

Article em En | MEDLINE | ID: mdl-29034299

Palavras-chave

IL, interleukin; JAK, Janus kinase; Janus kinase inhibitor; MCC, Merkel cell carcinoma; MCPyV, Merkel cell polyomavirus; Merkel cell carcinoma; RA, rheumatoid arthritis; STAT, signal transducers and activator of transcription; tofacitinib

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article